The post Market Analysis: November 13th, 2025 appeared first on Stock Target Advisor.

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

We begin with Argentine President Javier Milei, who has rejected investor calls to allow the peso to float freely following ...

Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...

NORTHAMPTON, MA / ACCESS Newswire / November 4, 2025 / Public policies are central factors in determining healthcare interventions and access to medicines and treatment. Viatris leverages our global ...

Over 3.5 years, patients randomized to 4 g of daily fish oil had a 43% lower risk for a composite of serious cardiovascular events compared with those assigned to placebo (0.31 vs 0.61 per 1,000 ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from ...

Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 as the biotech awaits key product launches from its partnership with ...

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. The Gaithersburg, Maryland-based ...

Novavax is pushing ahead with plans to slim down with a deal to offload one its locations in Maryland and surrounding property, which is expected to net $60 million in cash for the vaccine maker.